Fexofenadine_HCI: profile and news

Prasco to market generic Allegra Sep 13, 2005
Fexofenadine HCI is the most recent product from Prasco in its authorized generics program, which market brand company products under the Prasco label. - Cincinnati Business Courier,

Prasco and sanofi-aventis Sign a Distribution and Supply Agreement ... Sep 12, 2005
Fexofenadine HCI is the latest product from Prasco in its Authorized Generics program bringing consumers brand quality, generic priced pharmaceuticals. ... - Genetic Engineering News,

Barr, Teva to Sell Generic Allegra Sep 6, 2005
Shares of Albany Molecular Research Inc., which owns the patent for fexofenadine HCI, the active ingredient in Allegra, dropped sharply Tuesday. ... - Los Angeles Times,

Additional Allegra-D Patent Found Invalid Apr 6, 2005
Barr filed an Abbreviated New Drug Application (ANDA) for Fexofenadine HCI 60 mg capsules in May 2001, an ANDA for Fexofenadine HCI 30 mg, 60 mg, and 180 mg ... - Patent Baristas

Barr Granted Summary Judgment on Additional Patent in Allegra ... Apr 1, 2005
Barr filed an Abbreviated New Drug Application (ANDA) for Fexofenadine HCI 60 mg capsules in May 2001, an ANDA for Fexofenadine HCI 30 mg, 60 mg, and 180 mg ... - PharmaLive.com,